期刊文献+

cFLIP在压力超负荷诱导的心肌肥厚及纤维化中的作用 被引量:1

The role of cFLIP in cardiac hypertrophy and fibrosis induced by chronic pressure overload
下载PDF
导出
摘要 目的利用基因工程小鼠研究细胞型Fas相关死亡区域蛋白样β白介素-1转换酶抑制蛋白基因(cFLIP)在压力超负荷诱导的心肌肥厚及心肌纤维化中的作用。方法 cFLIP杂合子小鼠(heterozygote,HZ)和cFLIP野生型小鼠(wild type,WT)各20只分别随机分为模型组和假手术组,每组10只。主动脉缩窄术建立小鼠心肌肥厚模型,术后4周超声检测小鼠心室腔大小及左室短轴缩短率,组织病理学方法评价心肌肥厚及纤维化程度,实时定量聚合酶链式反应在mRNA水平检测心肌肥厚标志物心钠肽,脑钠肽,β-MHC以及心肌纤维化标志物结缔组织生长因子(CTGF),Ⅰ、Ⅳ型胶原(collagenⅠ,Ⅳ),TGF-β1。结果术后4周,HZ模型组较WT模型组和HZ假手术组心室腔增大,左室短轴缩短率下降(P<0.05,n=10);心肌肥厚及纤维化组织病理学检测及相关标志物表达水平模型组较假手术组升高(P<0.05,n=10),而HZ模型组表达增加程度较WT模型组更为显著(P<0.05,n=10)。结论cFLIP可抑制心肌肥厚及纤维化,对心功能起保护作用。 Objective To clarify the role of cellular Fas-associated death domain-like interleukin-1β-converting enzyme(FLICE)-like inhibitory protein(cFLIP)gene in cardiac hypertrophy and fibrosis induced by chronic pressure overload.Methods Twenty cFLIP heterozygote(HZ)mice and twenty wild-type cFLIP(WT)mice were randomly divided into model group and sham group equtionally(n=10).Cardiac hypertrophy model was established through aortic banding surgery.Four weeks after the aortic banding operation,cardiac function were evaluated by ultrasonic diagnosis equipment,and the degree of cardiac hypertrophy and fibrosis were evaluated by histological detection.In addition,the markers of cardiac hypertrophy including brain natriuretic peptide,atrial natriuretic peptide,and β-myosin heavy chain(β-MHC),fibrosis markers connective tissue growth factor(CTGF),transforming growth factor-β1(TGF-β1),and collagen Ⅰ,Ⅳ were detected by real-time quantitative polymerase chain reaction(PCR)at the mRNA level.Results Four weeks after the aortic banding operation,the physiological parameters and analysis of cardiac size and function of HZ group were reduced significantly(P0.05,n=10),and the degree of cardiac hypertrophy and fibrosis were increased dramatically(P0.05,n=10) while compared with those of WT group.Conclusion The cFLIP protects against the development of cardiac hypertrophy and fibrosis.
出处 《中国心脏起搏与心电生理杂志》 2012年第2期152-155,共4页 Chinese Journal of Cardiac Pacing and Electrophysiology
关键词 心血管病学 CFLIP 基因敲除 心肌肥厚 纤维化 心功能 Cardiology cFLIP Knock-out Cardiac hypertrophy Fibrosis Cardiac function
  • 相关文献

参考文献16

  • 1Judge DP. Use of genetics in the clinical evaluation of cardiomyopa-thy [J]. JAMA,2009,302 (22): 2 471.
  • 2Heineke J, Auger-Messier M, CorrellR N, et al. CIB1 is a regulator of pathological cardiac hypertrophy [ J]. Nat Med, 2010, 16 (8) : 872.
  • 3蒋丁胜,张艳,卞洲艳,纵静,周恒,严玲,李红良.早期生长应答因子-1在压力超负荷诱导的心肌肥厚及纤维化中的作用[J].中国心脏起搏与心电生理杂志,2011,25(3):253-257. 被引量:2
  • 4Xiao CW, Yan X, Li Y, et al. Resistance o f human ovarian cancer cells to tumor necrosis factor a is a consequence of nuclear factor KB- mediated induction of fas-associated death domain-like inter leukin- 1 [3-converting enzyme-like inhibitory protein [ J ]. Endocrinology, 2003, 144 (2) : 623.
  • 5Abedini MR, Qiu Q, Yan XJ, et al. Possible role of FLICE-Iike in- hibitory protein ( FLIP ) in chemoresistant ovarian cancer cells in vitro [J]. Oncogene, 2004, 23 (42) : 6 997.
  • 6Imanishi T, Murry CE, Reineeke H, et al. Cellular FLIP is ex- pressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues [ J]. Cardiovasc Res, 2000, 48 (1) : 101.
  • 7Steenbergen C, Afshari CA, Petranka JG, et al. Alterations in ap- optotic signaling in human idiopathic cardiomyopathic hearts in fail- ure [J]. Am J Physiol Heart Circ Physiol, 2003, 284 (l) : H268.
  • 8Thome M, Tschopp J. Regulation of lymphocyte proliferation and death by FLIP [J]. Nat Rev hnmunol, 2001, 1 (1) : 50.
  • 9Yeh WC, Itie A, Elia AJ, et al. Requirement fbr Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic de- velopment [J]. Immunity, 2000, 12 (6): 633.
  • 10Li HL, He CW, Feng JH, et al. Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechani- cal stress of pressure overload [J]. Proc Natl Acad Sci USA, 2010, 107 (31): 13818.

二级参考文献16

  • 1Lakdawala NK, Givertz MM. Dilated cardiomyopathy with conduction disease and arrhythmia[ J ], Circulation, 2010, 122 ( 5 ) : 527.
  • 2Judge DP. Use of genetics in the clinical evaluation of cardiomyopathy[J].JAMA, 2009, 302(22): 2471.
  • 3Heineke J, Auger-Messier M, Correll RN, et al. CIB1 is a regulator of pathological cardiac hypertrophy [ J ]. Nat Med, 2010, 16 (8) : 872.
  • 4Lorenz K, Schmitt JP, Schmitteckert EM, et al. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy [ J ]. Nat Med, 2009, 15 ( 1 ) :75.
  • 5Gashler A, Sukhatme V. Egr-1 : prototype of a zinc finger family of transcription factors[ J]. Prog Nucleic Acid Res Mol Biol, 1995, 50:191.
  • 6Levon M. Khachigian. Early growth response-1 in cardiovascular pathobiology[J].Circ Res, 2006, 98(2) : 186.
  • 7Li HL, He CW, Feng JH, et al. Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload[J]. PNAS, 2010, 107(31) : 13 818.
  • 8Bian ZY, Huang H, Jiang H, et al. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling[ J ]. Hypertension, 2010, 55 (2) : 257.
  • 9Saadane N, Alpert L, Chalifour LE, Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-l-deficient mice [J].Am J Physiol Heart Circ Physiol, 2000, 278(3) : H796.
  • 10Buitrago M, Lorenz K, Maass AH, et al. The transcriptional repressor Nabl is a specific regulator of pathological cardiac hypertrophy[J]. Nat Med, 2005, 11(8): 837.

同被引文献1

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部